Cite
HARVARD Citation
Stepanov, A. et al. (2023). Incidence of adverse events after loading phase of the brolucizumab therapy of neovascular AMD: Real-life evidence in the Czech Republic. European journal of ophthalmology. 33 (2), pp. 1097-1104. [Online].